Public Profile

Dynavax Technologies Corporation

Dynavax Technologies Corporation, commonly referred to as Dynavax, is a prominent biopharmaceutical company headquartered in the United States. Founded in 1996, Dynavax has established itself in the immunotherapy sector, focusing on the development of innovative therapies for infectious diseases and cancer. The company is renowned for its flagship product, HEPLISAV-B, a unique hepatitis B vaccine that offers enhanced protection with a two-dose regimen. This product exemplifies Dynavax's commitment to advancing vaccine technology and improving patient outcomes. With a strong market position, Dynavax has achieved significant milestones, including successful collaborations and partnerships that bolster its research and development efforts. The company continues to expand its operational footprint, contributing to the evolving landscape of immunology and infectious disease management.

DitchCarbon Score

How does Dynavax Technologies Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

19

Industry Benchmark

Dynavax Technologies Corporation's score of 20 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.

22%

Let us know if this data was useful to you

Dynavax Technologies Corporation's reported carbon emissions

Dynavax Technologies Corporation, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments in detail. However, the absence of reported data may indicate a need for enhanced transparency in their environmental impact reporting. As the biopharmaceutical industry increasingly prioritises sustainability, Dynavax may benefit from establishing clear climate goals and initiatives to align with industry standards and stakeholder expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Dynavax Technologies Corporation's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Dynavax Technologies Corporation is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Dynavax Technologies Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Merck And Co

US
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Janssen

US
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Gilead Sciences

US
Research and development services (73)
Updated 12 days ago

Novavax, Inc.

US
Health and social work services (85)
Updated 23 days ago

Biontech

DE
Research and development services (73)
Updated about 17 hours ago

Takeda

JP
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers